Khairunnisa Mohd Kamal1, Ahmad Rohi Ghazali1, Gayathri Thevi Selvarajah2, Nurul Syakima Ab Mutalib3, Nadiah Abu3, Eng Wee Chua4, Siti Fathiah Masre1*
1. Biomedical Science Programme, Centre for Toxicology and Health Risk Studies (CORE), Faculty of Health Sciences, Universiti Kebangsaan Malaysia (UKM), 50300 Kuala Lumpur, Malaysia
2. Department of Veterinary Clinical Studies, Faculty of Veterinary Medicine, Universiti Putra Malaysia (UPM), 43400 Serdang, Malaysia
3. UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia (UKM), 56000 Cheras, Kuala Lumpur, Malaysia
4. Centre for Drug and Herbal Development, Faculty of Pharmacy, Universiti Kebangsaan Malaysia (UKM), 50300 Kuala Lumpur, Malaysia
*Corresponding author: Siti Fathiah Masre.
ABSTRACT
INTRODUCTION: Aberrant DNA methylation is a key driver in lung cancer development and progression. DNA methyltransferase (DNMT) inhibitors, such as 5-aza-2’-deoxycytidine (5-aza-dC), have shown potential in reversing these epigenetic changes. However, their histological effects—particularly on epithelial architecture and extracellular matrix remodelling—remain poorly characterised.
OBJECTIVE(S): This study aimed to investigate the impact of DNMT inhibition on epithelial thickness and collagen deposition in a dual-stage N-nitroso-tris-chloroethylurea (NTCU)-induced lung squamous cell carcinoma (SCC) mouse model.
MATERIALS & METHODS: BALB/c mice were divided into pre-malignant (PM, 15 weeks) and malignant (M, 30 weeks) SCC groups, induced using topical NTCU. Each stage comprised three subgroups (n = 6): control (70% acetone), cancer (0.04 M NTCU), and DNMT inhibitor (0.04 M NTCU + 0.25 mg/kg 5-aza-dC, intraperitoneal). Histological analysis assessed epithelial thickness by haematoxylin and eosin (H&E) staining, followed by cytokeratin 5/6 (CK 5/6) expression confirmation by immunohistochemistry and collagen deposition by Sirius Red.
RESULTS: Histological evaluation confirmed successful induction of dual-stage SCC in NTCU-treated groups. The 5-aza-dC group exhibited more distinct SCC features than the cancer group, supported by CK 5/6 immunostaining. Both cancer and DNMT inhibitor groups showed significantly increased epithelial thickness and collagen deposition compared to controls (p < 0.05). In the malignant stage, epithelial thickness and collagen deposition were significantly higher in the NTCU-only group than in the 5-aza-dC group (p < 0.05), while no significant differences were observed in CK 5/6 expression. Stage-wise comparison showed elevated epithelial thickness and collagen content in the malignant versus pre-malignant stage for the NTCU-only group, whereas the 5-aza-dC group exhibited stable levels across both stages.
CONCLUSION: This study demonstrates that DNMT inhibition influences histological features of lung SCC, reducing epithelial thickening and collagen deposition in a dual-stage carcinogenesis model. To our knowledge, this is the first report to describe these histological outcomes of DNMT inhibition in an established mouse lung SCC model.
KEYWORDS: DNA Methyltransferases, 5-aza-2’-deoxycytidine, Lung Squamous Cell Carcinoma, Epithelium Thickness, Collagen Deposition


